Attention: This platform is in beta mode. Expect some changes and adjustments.

AI Market Mood: Stock Dashboard

AVNS


Fundamental

Company: Avanos Medical Inc
Sector: Healthcare
Industry: Medical Devices
Country: USA
Exchange: NYSE
Index: RUT
P/E: 49.66
EPS (ttm): 0.34
Insider Own: 2.47%
Shs Outstand: 45.95M
Perf Week: -1.18%
Market Cap: 769.78M
Forward P/E: 9.85
EPS next Y: 1.70
Insider Trans: 0.00%
Shs Float: 44.82M
Perf Month: 5.21%
Income: 15.70M
PEG: 2.02
EPS next Q: 0.40
Inst Own: 95.05%
Short Float: 1.49%
Perf Quarter: -9.85%
Sales: 681.50M
P/S: 1.13
EPS this Y: 28.64%
Inst Trans: 2.29%
Short Ratio: 1.47
Perf Half Y: -29.47%
Book/sh: 26.76
P/B: 0.63
EPS next Y Percentage: 28.30%
ROA: 1.28%
Short Interest: 0.67M
Perf Year: -12.71%
Cash/sh: 1.94
P/C: 8.65
EPS next 5Y: 24.55%
ROE: 1.77%
52W Range From: 14.98
52W Range To: 25.36
Perf YTD: 5.21%
Dividend Est.: -
P/FCF: 21.03
EPS past 5Y: -
ROI: 1.11%
52W High: -33.95%
Beta: 1.15
Dividend TTM: -
Quick Ratio: 1.46
Sales past 5Y: -0.77%
Gross Margin: 55.51%
52W Low: 11.82%
ATR (14): 0.56
Dividend Ex-Date: -
Current Ratio: 2.22
EPS Y/Y TTM: 128.82%
Oper. Margin: 9.16%
RSI (14): 51.77
Volatility W: 3.10%
Volatility M: 3.48%
Employees: 3771
Debt/Eq: 0.16
Sales Y/Y TTM: -9.12%
Profit Margin: 2.30%
Recom: 3.00
Target Price: 20.00
Option/Short: Yes / Yes
LT Debt/Eq: 0.15
EPS Q/Q: 216.69%
Payout: -
Rel Volume: 0.00
Prev Close: 16.75
Sales Surprise: -2.81%
EPS Surprise: -6.59%
Sales Q/Q: -0.53%
Earnings: Oct 30 BMO
Avg Volume: 454.44K
Price: 16.75
SMA20: 3.78%
SMA50: -1.97%
SMA200: -17.55%
Trades:
Volume: 0
Change: 0.00%

Technical:


Latest News:

Thermo Fisher (TMO) Partners With ArsenalBio for Cancer R&D - Yahoo News NZ somewhat bullish
TMO HAE CPRX AVNS

Summary: Thermo Fisher Scientific announced a collaboration with Arsenal Biosciences to develop manufacturing processes for new cancer treatments, focusing on next-generation, programmable autologous T cells. Thermo Fisher's Cell Therapy Systems product line will assist ArsenalBio in creating multi-functional CAR-T cell therapies.

Full article
2024-05-17T13:51:43Z